C19ORF24 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.187400E-01
Normal-vs-Stage2
8.516200E-01
Normal-vs-Stage3
3.446200E-01
Normal-vs-Stage4
8.078000E-01
Stage1-vs-Stage2
5.968000E-01
Stage1-vs-Stage3
2.351600E-01
Stage1-vs-Stage4
4.873000E-01
Stage2-vs-Stage3
2.785000E-01
Stage2-vs-Stage4
6.824200E-01
Stage3-vs-Stage4
4.845000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.023800E-01
Normal-vs-AfricanAmerican
7.987800E-01
Normal-vs-Asian
7.640100E-02
Caucasian-vs-AfricanAmerican
7.020800E-01
Caucasian-vs-Asian
8.386100E-02
AfricanAmerican-vs-Asian
6.384200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.572400E-01
Normal-vs-Female
7.646400E-01
Male-vs-Female
9.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.918000E-01
Normal-vs-Age(41-60Yrs)
9.140400E-01
Normal-vs-Age(61-80Yrs)
8.403000E-01
Normal-vs-Age(81-100Yrs)
4.492200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.366000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.770200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.779000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.204200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.542100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.360200E-01
Normal-vs-Daily Drinker
5.713000E-01
Normal-vs-Weekly Drinker
1.701630E-01
Normal-vs-Occasional Drinker
7.611800E-01
Normal-vs-Social Drinker
9.303600E-01
Non Drinker-vs-Daily Drinker
1.284570E-01
Non Drinker-vs-Weekly Drinker
1.515020E-01
Non Drinker-vs-Occasional Drinker
4.246600E-01
Non Drinker-vs-Social Drinker
7.440600E-01
Daily Drinker-vs-Weekly Drinker
5.376600E-01
Daily Drinker-vs-Occasional Drinker
5.702200E-01
Daily Drinker-vs-Social Drinker
2.455000E-01
Weekly Drinker-vs-Occasional Drinker
3.175200E-01
Weekly Drinker-vs-Social Drinker
2.024400E-01
Occasional Drinker-vs-Social Drinker
6.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.741400E-01
Normal-vs-Grade 2
7.679800E-01
Normal-vs-Grade 3
4.124600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.931800E-01
Grade 1-vs-Grade 3
4.025800E-01
Grade 1-vs-Grade 4
6.741400E-01
Grade 2-vs-Grade 3
9.562600E-01
Grade 2-vs-Grade 4
7.679800E-01
Grade 3-vs-Grade 4
4.124600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.480600E-01
Normal-vs-NonDiabetic
6.753000E-01
Diabetic-vs-NonDiabetic
5.997000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.374000E-01
Normal-vs-NoPancreatitis
7.820000E-01
Pancreatitis-vs-NoPancreatitis
3.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.012600E-01
Normal-vs-N1
9.094400E-01
N0-vs-N1
2.897200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.627400E-01
Normal-vs-TP53-NonMutant
8.053800E-01
TP53-Mutant-vs-TP53-NonMutant
4.852000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
